Back to Journals » Journal of Hepatocellular Carcinoma » Volume 11

Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma

Total article views   HTML views PDF downloads Totals
1,383 Dovepress* 1,273+ 29 1,302
PubMed Central* 110 49 159
Totals 1,383 78 1,461
*Since 4 March 2024
Total mentioned Facebook Delicious Reddit Twitter Others
10 0 0 0 5 5

View citations on PubMed and Google Scholar